Effect of 12 neutralizing anti-cytokine antibodies on in vitro activation of B-cells. Interleukin-12 is required by B1a but not B2 cells

Scandinavian Journal of Immunology

Volumn 43, Issue 1, 1996, Pages 64-72

  Jones, B M ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; CYTOKINE ANTIBODY; INTERLEUKIN 12; POKEWEED MITOGEN;

ADULT; ARTICLE; B LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; NORMAL HUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0030045053     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-4.x     Document Type: Article

References (31)

1. Hayakawa K, Hardy RR, Herzenberg LA, Herzenberg LA. Progenitors for Ly-1 B-cells are distinct from progenitors for other B-cells. J Exp Med 1985;161:1554-68.
2. Marcos MAR, Caspar ML, Malenchere E, Coutinho A. Isolation of peritoneal precursors of B-1 cells in the adult mouse. Eur J Immunol 1994;24:1033-40.
3. + B cells. Blood 1989;73: 202-8.
4. Vernino LA, Pisetsky DS, Lipsky PE. Analysis of the expression of CD5 by human B cells and correlation with functional activity. Cell Immunol 1992;139:185-97.
5. Casali P, Notkins AL. B-lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989;10:364-8.
6. + B-lymphocytes. Ann Rev Immunol 1989;7:513-35.
7. Bona CA. V genes encoding autoantibodies: molecular and phenotypic characteristics. Ann Rev Immunol 1988;6:327-58.
8. Grabar P. Autoantibodies and the physiological role of immunoglobulins. Immunol Today 1983;4:337-40.
9. Cohen IR, Cooke A. Natural autoantibodies might prevent autoimmune disease. Immunol Today 1986;7:363-4.
10. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 1991;12:154-9.
11. Jones BM, Cheng IKP, Wong RWS, Kung AWC. CD5-positive and CD5- negative rheumatoid factor-secreting B cells in IgA nephropathy, rheumatoid arthritis and Graves' disease. Scand J Immunol 1993;38:575-80.
12. + B-lymphocytes are as dependent on T-helper cells and as responsive to T-suppressor cells in pokeweed mitogen-stimulated activation as conventional CD5 B-lymphocytes. Scand J Immunol 1991;33:387-92.
13. Jones BM, Cheng IKP, Wong RWS. Aberrant T-regulation in rheumatoid arthritis and IgA nephropathy affects CD5 and CD5 B-lymphocytes equally. Clin Exp Immunol 1991;86:212-8.
14. Jones BM. Evaluation of CD5 and other differentiation antigens on human immunoglobulin-secreting cells using a combination of immunobead rosetting and reverse haemolytic plaque formation. J Immunol Methods 1990;132:119-26.
15. Jones BM. Clinical evaluation of B-cell and T-regulator cell function using a protein A haemolytic plaque assay. Clin Exp Immunol 1981;46:196-205.
16. Sauerwein RW, Mudde GC, Vooys WC, van der Meer WGJ, de Gast GC, Al Aarden L. Induction of IgM production by pokeweed mitogen and interleukin-2: different responses by human peripheral blood cells and tonsil cells. Clin Immunol Immunopathol 1986;39:431-41.
17. Teranishi T, Hirano T, Lin BH, Onoue K. Demonstration of the involvement of interleukin 2 in the differentiation of Staphylococcus aurcus Cowan I-stimulated B-cells. J Immunol 1984;133: 3062-7.
18. Kinashi T, Harada N, Severinson E et al. Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 1986;324:70-3.
19. Roussel F, Garcia E, DeFrance T et al. Interleukin 10 is a potent growth and differentiation factor for activated human B-lymphocytes. Proc Nat Acad Sci USA 1992;89:1890-3.
20. Nonoyama S, Farrington ML, Ochs HD. Effect of IL-2 on immunoglobulin production by anti-CD40-activated human B-cells: synergistic effect with IL-10 and antagonistic effect with IL-4. Clin Immunol Immunopathol 1994;72:373-9.
21. Hirano T, Taga T, Nakano N et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Nat Acad Sci USA 1985;82:5490-4.
22. Boussiotis VA, Nadler LM, Strominger JL, Goldfeld AE. Tumour necrosis factor α is an autocrine growth factor for normal human B cells. Proc Nat Acad Sci USA 1994;91:7007-11.
23. Wahl SM. Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J Clin Immunol 1992;12:61-74.
24. Pike BL, Nossal GJV. Interleukin 1 can act as a B-cell growth and differentiation factor. Proc Nat Acad Sci USA 1985;82: 8153-7.
25. Kotowicz K, Callard RE. Human immunoglobulin class and IgG subclass regulation: dual action of interleukin-4. Eur J Immunol 1993;23:2250-6.
26. Leibson HJ, Gefter M, Zlotnik A, Marrack P, Kappler JW. Role of γ-interferon in antibody-producing responses. Nature 1984; 309:799-801.
27. Cocks BG, de Waal Malefyt R, Galizzi J-P, de Vries JE, Aversa G. IL-13 induces proliferation and differentiation of human B-cells activated by the CD40 ligand. Int Immunol 1993;5:657-63.
28. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 1993;14:335-8.
29. Jelinek DF, Braaten JK. Role of IL-12 in human B-lymphocyle proliferation and differentiation. J Immunol 1995;154: 1606-13.
30. Desai BB, Quinn PM, Wolitzky AG, Mongini PKA, Chizzonite R, Gately MK. IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol 1992;148:3125-32.
31. Boumsell L, Coppin H, Pham D et al. An antigen shared by a human T cell subset and B cell chronic lymphocytic leukaemia cells. J Exp Med 1980; 152:229-34.